Immune microenvironment analysis revealed that blocking the CXCL8/CXCR1/2 pathway reduced the infiltration of MDSCs and tumor-associated neutrophils while enhancing the infiltration and activity of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.